rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1994-2-9
|
pubmed:abstractText |
This study was conducted to assess the efficacy of sulodexide, a glycosaminoglycan compound with antithrombotic properties, in preventing death and thromboembolic events after acute myocardial infarction.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0735-1097
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
27-34
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8277091-Aged,
pubmed-meshheading:8277091-Cardiovascular Diseases,
pubmed-meshheading:8277091-Cause of Death,
pubmed-meshheading:8277091-Female,
pubmed-meshheading:8277091-Glycosaminoglycans,
pubmed-meshheading:8277091-Heart Diseases,
pubmed-meshheading:8277091-Humans,
pubmed-meshheading:8277091-Hypolipidemic Agents,
pubmed-meshheading:8277091-Male,
pubmed-meshheading:8277091-Middle Aged,
pubmed-meshheading:8277091-Myocardial Infarction,
pubmed-meshheading:8277091-Prospective Studies,
pubmed-meshheading:8277091-Recurrence,
pubmed-meshheading:8277091-Thrombolytic Therapy,
pubmed-meshheading:8277091-Thrombosis,
pubmed-meshheading:8277091-Time Factors
|
pubmed:year |
1994
|
pubmed:articleTitle |
IPO-V2: a prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarction.
|
pubmed:affiliation |
Department of Medicine, School of Medicine, Federico II University, Naples, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|